News
Up one levelSite News
U.S. Colleges Report Rise in 'Flu-like' Illness
U.S. colleges in the Midwest and Southeast are already reporting flu-like illnesses, though the school year has scarcely begun. Most have not tested for H1N1, but most reported cases are likely to be attributable to the 2009 "swine flu."
Search PubMed Pandemic Flu Research Listings
The NIH maintains a list of related research publications relevant to public health planning for pandemic influenza.
It's Official: Pandemic Phase 6 Reached
The UN's World Health Organization announced on 11 June 2009 that it had raised the H1N1 outbreak to pandemic phase 6.
Guardian Reviews UK's 2007 Pandemic Flu Plan
As part of its swine flu coverage, highlighted by the revelation on the same day that two UK citizens were confirmed to have contracted the disease, the Guardian reviewed the British government's pandemic flu contingency plan.
H1N1 Outbreak "Public Health Emergency"
It's "standard operating procedure," says DHS Secretary Janet Napolitano, but she advises that "preparatory steps" are being taken by the government.
U.S. National Biosurveillance Integration System
Proposed DHS system to give the agency real time data from systems maintained by other agencies.
About PandemicSimulation.com
Preparing for a pandemic requires expertise that is both broad and deep. PandemicSimulation.com seeks to deepen understanding of modeling, game and simulation issues, to foster community contributions to common needs and to build software solutions.
adlCommunity.net to use Moodle
The US DoD Advanced Distributed Learning initiative created a new virtual community, adlCommunity.net, and selected Moodle products to power it.
FDA Approves First U.S. Vaccine vs. H5N1
The sanofi pasteur vaccine, which demonstrated effectiveness for about half of the humans receiving it during test trials, will be stockpiled by the U.S. Government and will not be sold commercially.
IMS LIA Finalists Include Open University Project
Finalists in the IMS "new" category include OpenLearn at the Open University, United Kingdom. OpenLearn is supported by Moodle.
Influenza Prediction Market launched
Citing delays of 1-2 weeks in the CDC's current influenza surveillance operations, an Influenza Prediction Market service hopes to improve predictions and hence public health preparations.
Vaccine effective less than half the time?
A fresh look at last year's clinical trials data is cause for concern.
Commentaries and Summaries
In the "Strategies" section of this site, commentaries and summaries of other research will be provided.
2,500 British Turkeys Die of H5N1
There have been no reports of preparedness adjustments in response to the death of 2,500 turkeys infected by H5N1 at a single farm near Lowestoft in the British county of Suffolk. Separately, the WHO confirmed a human H5N1 fatality in Nigeria, the first in sub-Saharan Africa.
Idaho Preparedness Group Adds Virtual ISO-POD
The Idaho Bioterrorism Awareness and Preparedness Program is experimenting with a virtual version of an ISO-POD to its Second Life medical world. The ISO-POD is a bio-isolation transport and temporary isolation solution for first responders built by TVI Corporation. TVI is also a supplier of hospital surge, filtration, decontamination, first responder trailers and related equipment.
Resurgent Game-maker Acclaim To Meet Bird Flu?
Acclaim Entertainment ceased operations in 2005, but Howard Marks bought what assets remained and relaunched the company as "Acclaim Games." Marks is scheduled to speak at the Game Developer 2007 conference on the subject of "Bird Flu."
H5N1 DNA Vaccine Trials Begin
The first NIH volunteer received a DNA-based H5N1 vaccine at the NIH Clinical Center in Bethesda. The candidate vaccine was the NIH vaccine off the assembly line at a new plant.
Strategy Redux: Nothing New Since 1918?
An October 2006 workshop at NIH featured reports from medical historians about strategies employed during the 1918 pandemic. Upshot? Use the same strategies again.
Pandemicsimulation.com - H1N1 Recommended Sites
Forgot your password?
New user?
